Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Forest Laboratories
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Currently have an ICD implanted
Have had a documented episode of symptomatic arrhythmias that triggered a spontaneous ICD shock within 180 days of randomization.
If the ICD implant is recent, the patient must have had a documented episode of sustained arrhythmias or cardiac arrest within 42 days before implantation of the ICD
You may not be if
have severe heart failure
have a current diagnosis of psychosis
use illicit drugs
abuse alcohol
if female, are currently breast feeding, or plan to become pregnant during the study
are currently taking antiarrhythmic drugs or other drugs that prolong the QTc interval (a measurement taken from the ECG)
creatinine \>2.5 mg/dL (221 mmol/L)
potassium \<4.0 mEq or \>5.5 mEq
have a neutrophil count (ANC) \< 100 mL (low count of a type of white blood cell) at time of randomization
have 2 or more consecutive QTc values \>440 msec
Clareo Health | Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators
